What Is Thalassemia? Causes, Symptoms, Treatment and the Importance of Blood Donation

India’s tradition of service, sacrifice and compassion encourages us to understand the suffering of others. Children living with thalassemia and their families need that understanding, together with consistent support. Hospital visits, investigations and treatment can become part of everyday life. Reliable information and voluntary blood donation can offer hope and help families access support when it is needed.

How Is Thalassemia Passed from Parents to Children?

Thalassemia is an inherited blood disorder passed from parents to children through genes. It affects the production of hemoglobin, the protein in red blood cells that carries oxygen throughout the body. Reduced hemoglobin production can cause anemia, tiredness and other health problems. Alpha and beta thalassemia are its main genetic types.[1]

Thalassemia cannot be caught through ordinary contact, sitting together or sharing food. A child’s condition is not caused by something the parents did wrong during pregnancy. Many carriers only discover their status after testing. Families deserve understanding, respect and appropriate counseling.[2]

Thalassemia minor, or trait, usually allows a person to lead a healthy life, although mild anemia may occur. Carrier status does not later turn into thalassemia major. Thalassemia major is a serious condition that may require regular blood transfusions. The severity and treatment needs of thalassemia intermedia vary between individuals.[3] [4]

These probabilities apply independently to each pregnancy. They do not predict a fixed sequence of outcomes in a family with four children. Alpha thalassemia follows a different, more complex inheritance pattern.[2]

Recognizing Symptoms and Getting the Right Tests

Symptoms of severe beta thalassemia may begin a few months after birth. They can include pale skin, marked tiredness, weakness, breathlessness, a rapid heartbeat and yellowing of the eyes. Children may grow more slowly, and some patients develop changes in bone growth. These symptoms call for medical assessment.[5]

Doctors may recommend a complete blood count (CBC), specialized hemoglobin testing such as HPLC, and genetic testing when needed. A low hemoglobin result alone does not establish a diagnosis of thalassemia. Accurate interpretation of reports and confirmation at a specialist center are important, particularly in complex cases.[6]

Voluntary carrier screening can be useful before planning a family. If both partners are carriers, genetic counseling can help them understand the risks and available choices. During pregnancy, early specialist advice and appropriate prenatal testing may be discussed. Decisions should respect informed consent, privacy and each family’s circumstances.[3]

Why Regular Transfusions and Medicines Matter

Regular red blood cell transfusions, usually using packed red blood cells (PRBCs), are an important part of care for transfusion-dependent thalassemia. The timing and amount are determined by the patient’s clinical needs. Many patients require this support over the long term, sometimes throughout life.[6]

Repeated transfusions can cause excess iron to accumulate in the body, increasing the risk of organ damage. Doctors use iron chelation therapy to help control this buildup. Taking prescribed medicines consistently, attending investigations and receiving ongoing medical supervision are essential parts of care. People with thalassemia minor or trait generally do not need regular transfusions.[4]

Bone Marrow Transplantation and Donor Matching

For suitable patients, a bone marrow or hematopoietic stem cell transplant can offer the possibility of a cure. Donor selection involves HLA tissue matching and specialist assessment beyond blood group compatibility. The team considers the patient’s age, health and possible complications. Transplantation can be complex and expensive, and suitability must be assessed individually.[6] [7]

Gene-based treatment options have also been developed. In the United States, gene therapy has been approved for some eligible patients with beta thalassemia. Availability, cost and an individual patient’s eligibility in India should be clarified with the relevant specialist center.[4]

Why Voluntary Blood Donation Matters for Thalassemia

For families supporting a patient who needs repeated transfusions, finding suitable blood on time can be a continuing concern. Regular voluntary donors and donation camps working with authorized blood centers can help meet this need. The blood center provides an appropriate blood component after testing and the required compatibility checks.[8]

Blood donors, camp organizers, doctors, technicians and social workers all contribute to this effort. Listening to families, connecting them with treatment centers and helping when support is needed are equally valuable. The blood center should confirm each donor’s eligibility and the appropriate interval between donations.

A blood donor in every home.
Join the commitment to a Thalassemia-Free India.